Seelos Therapeutics to Participate in the Cantor Virtual Global Healthcare Conference

Rhea-AI Summary

Seelos Therapeutics, Inc. (Nasdaq: SEEL) announced its participation in the Cantor Virtual Global Healthcare Conference from September 15-17, 2020. Raj Mehra, Ph.D., Chairman and CEO, will host individual meetings via conference calls. The company focuses on developing therapies for central nervous system disorders and rare diseases, with a portfolio addressing conditions like Major Depressive Disorder, PTSD, and ALS. For more details on the conference, visit Cantor Healthcare Conference.

NEW YORK, Aug. 28, 2020 /PRNewswire/ -- Seelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system disorders and rare diseases, today announced that it will participate in the Cantor Virtual Global Healthcare Conference, September 15-17, 2020.

Raj Mehra, Ph.D., Chairman and CEO, will host 1x1 meetings via conference calls.

For additional information about the Cantor Virtual Global Healthcare Conference: https://www.cantor.com/global-healthcare-2020/

About Seelos Therapeutics:
Seelos Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the development and advancement of novel therapeutics to address unmet medical needs for the benefit of patients with central nervous system (CNS) disorders and other rare diseases. The Company's robust portfolio includes several late-stage clinical assets targeting indications including Acute Suicidal Ideation and Behavior (ASIB) in Major Depressive Disorder (MDD) or Post-Traumatic Stress Disorder (PTSD),  Amyotrophic lateral sclerosis (ALS), Sanfilippo syndrome, Parkinson's Disease, other psychiatric and movement disorders plus orphan diseases.

For more information, please visit our website: http://seelostherapeutics.com, the content of which is not incorporated herein by reference.

Contact Information:

Anthony Marciano
Head of Corporate Communications
Seelos Therapeutics, Inc. (Nasdaq: SEEL)
300 Park Ave., 12th Fl
New York, NY 10022
(646) 293-2136
anthony.marciano@seelostx.com
https://seelostherapeutics.com/
https://twitter.com/seelostx
https://www.linkedin.com/company/seelos

 

View original content to download multimedia:http://www.prnewswire.com/news-releases/seelos-therapeutics-to-participate-in-the-cantor-virtual-global-healthcare-conference-301120010.html

SOURCE Seelos Therapeutics, Inc.

FAQ

When will Seelos Therapeutics participate in the Cantor Virtual Global Healthcare Conference?

Seelos Therapeutics will participate in the Cantor Virtual Global Healthcare Conference from September 15-17, 2020.

Who is hosting the meetings for Seelos Therapeutics at the conference?

Raj Mehra, Ph.D., Chairman and CEO of Seelos Therapeutics, will host the meetings.

What is the primary focus of Seelos Therapeutics?

Seelos Therapeutics focuses on developing therapies for central nervous system disorders and rare diseases.

What conditions are targeted by Seelos Therapeutics' portfolio?

Seelos Therapeutics targets conditions such as Major Depressive Disorder, PTSD, ALS, and other rare diseases.

Where can I find more information about Seelos Therapeutics?

More information can be found on Seelos Therapeutics' website at http://seelostherapeutics.com.